MENS (Jyong Biotech) Long-Term Debt: $10.16 Mil (As of Dec. 2025)


MENS Jyong Biotech Ltd MENS
10 GF Score
Price $2.24
! 3 Warning Signs
View Full Analysis

What is Jyong Biotech Long-Term Debt?

Jyong Biotech MENS -3.28% 10 Long-Term Debt is $10.16 Mil as of Dec. 2025. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Jyong Biotech's Long-Term Debt for the quarter that ended in Dec. 2025 was $10.16 Mil.

Jyong Biotech's quarterly Long-Term Debt increased from Dec. 2024 ($10.68 Mil) to Jun. 2025 ($12.27 Mil) but then declined from Jun. 2025 ($12.27 Mil) to Dec. 2025 ($10.16 Mil).

Jyong Biotech's annual Long-Term Debt increased from Dec. 2023 ($8.52 Mil) to Dec. 2024 ($10.68 Mil) but then declined from Dec. 2024 ($10.68 Mil) to Dec. 2025 ($10.16 Mil).

Jyong Biotech  (NAS:MENS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Jyong Biotech Long-Term Debt Related Terms

Jyong Biotech Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Jyong Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jyong Biotech Long-Term Debt Chart

Jyong Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
6.26 6.32 8.52 10.68 10.16

Jyong Biotech Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial 8.52 9.67 10.68 12.27 10.16
MENS
10GF Score
Jyong Biotech Ltd MENS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $10.16 Mil mean?
Jyong Biotech (MENS) has a Long-Term Debt of $10.16 Mil as of Dec. 2025.
Is Jyong Biotech's Long-Term Debt too high?
Jyong Biotech's current Long-Term Debt is $10.16 Mil. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Long-Term Debt compare to ENLV and CNTB?
Jyong Biotech's Long-Term Debt of $10.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Jyong Biotech's current Long-Term Debt is $10.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Long-Term Debt of $10.16 Mil. The current Long-Term Debt is $10.16 Mil. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Long-Term Debt is $10.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jyong Biotech Business Description

Address Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score

Get the complete analysis for MENS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price